CareDx, Inc. (CDNA) vs RadNet, Inc. (RDNT)
CareDx, Inc. and RadNet, Inc. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $5.6B against $3.2B — 1.8× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; CareDx, Inc. trades at 29.6×. CareDx, Inc. grew revenue faster over the last twelve months: 34.4% against 18.9%. CareDx, Inc. has the higher net margin (24.2% vs −0.93%) and the higher return on invested capital (130.1% vs 2.24%). Across the 20 metrics below, CareDx, Inc. leads on 15 and RadNet, Inc. on 5.
Valuation
Profitability
| Metric | CDNA | RDNT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 70.58% | 11.53% | 50.89% |
| Operating margin | 23.61% | 3.12% | (8.57%) |
| Net margin | 24.23% | (0.93%) | (6.37%) |
| Free cash flow margin | 18.49% | 3.28% | 0.00% |
| Return on equity | 29.49% | (1.64%) | (2.92%) |
| Return on assets | 22.72% | (0.55%) | (6.71%) |
| Return on invested capital | 130.06% | 2.24% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack